Iridex (IRIX) Other Non-Current Liabilities (2011 - 2026)
Iridex's (IRIX) quarterly Other Non-Current Liabilities came in at $440000.0 in Q2 2026, up 51.72% year-on-year from $290000.0 in Q2 2025, and up 13.7% quarter-over-quarter from $387000.0 in Q1 2026.
Iridex (IRIX) Other Non-Current Liabilities (2011 - 2026) Analysis & Trends
Iridex's Other Non-Current Liabilities history runs 16 years deep, the most recent figure standing at $440000.0 for Q2 2026.
- On a quarterly basis, Other Non-Current Liabilities rose 51.72% year-over-year to $440000.0 in Q2 2026; TTM through Apr 2026 was $440000.0, a 51.72% increase from a year earlier, with the FY2026 full-year figure at $387000.0, up 23.25% from the prior year.
- Other Non-Current Liabilities rose to $440000.0 in Q2 2026 per IRIX's latest filing, from $387000.0 in the prior quarter.
- Across five years, Other Non-Current Liabilities topped out at $440000.0 in Q2 2026 and bottomed at $24000.0 in Q2 2022.
- The 5-year median for Other Non-Current Liabilities is $227000.0 (2023), against an average of $197666.7.
- Across the five-year window, Other Non-Current Liabilities soared 1112.0% in 2024 and slipped 4.61% in 2025, its largest moves.
- Year by year, Other Non-Current Liabilities stood at $26000.0 in 2022, then soared by 530.77% to $164000.0 in 2023, then soared by 91.46% to $314000.0 in 2024, then gained by 0.32% to $315000.0 in 2025, then soared by 39.68% to $440000.0 in 2026.
- Per Business Quant, the three latest IRIX Other Non-Current Liabilities figures stand at $440000.0 (Q2 2026), $387000.0 (Q1 2026), and $315000.0 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | Iridex | 15.93 Mn | 11.33 Mn | 4.74 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 4, 2026 | 440,000.00 |
| Jan 3, 2026 | 387,000.00 |
| Sep 27, 2025 | 315,000.00 |
| Jun 28, 2025 | 307,000.00 |
| Mar 29, 2025 | 290,000.00 |
| Dec 28, 2024 | 314,000.00 |
| Sep 28, 2024 | 321,000.00 |
| Jun 29, 2024 | 303,000.00 |
| Mar 30, 2024 | 304,000.00 |
| Dec 30, 2023 | 164,000.00 |
| Sep 30, 2023 | 138,000.00 |
| Jul 1, 2023 | 25,000.00 |
| Apr 1, 2023 | 124,000.00 |
| Dec 31, 2022 | 26,000.00 |
| Oct 1, 2022 | 27,000.00 |
| Jul 2, 2022 | 24,000.00 |
| Apr 2, 2022 | 24,000.00 |
| Jan 1, 2022 | 25,000.00 |
| Oct 2, 2021 | 22,000.00 |
| Jul 3, 2021 | 22,000.00 |